Keros Therapeutics Inc.

NASDAQ: KROS · Real-Time Price · USD
15.62
-0.18 (-1.14%)
At close: Sep 17, 2025, 3:59 PM
15.62
0.00%
After-hours: Sep 17, 2025, 04:20 PM EDT
-1.14%
Bid 15
Market Cap 634.41M
Revenue (ttm) 232.84M
Net Income (ttm) 18.77M
EPS (ttm) 0.32
PE Ratio (ttm) 48.81
Forward PE -3.6
Analyst Hold
Dividends n/a
Ask 16.29
Volume 172,697
Avg. Volume (20D) 453,187
Open 15.97
Previous Close 15.80
Day's Range 15.53 - 16.11
52-Week Range 9.12 - 72.37
Beta 1.07
Ex-Dividend Date n/a

About KROS

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol KROS
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for KROS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
Keros Therapeutics Inc. is scheduled to release its earnings on Nov 5, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-7.29%
Keros Therapeutics shares are trading lower follow... Unlock content with Pro Subscription
5 months ago
+18.49%
Keros Therapeutics shares are trading higher. The company announced that its board has initiated a formal review process to evaluate strategic alternatives to maximize shareholder value.